High materiality7/10
Vir Biotechnology price target lowered to $25 from $27 at Morgan Stanley
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley lowers VIR Biotechnology target to $25 from $27; current price $9.11; price since signal down by $3.18.
- Target down to $25
- Posted price $9.11
- Price change since signal -$3.18
Key facts
- 01
Target: $25
- 02
Posted price: $9.11
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.